TTRX
Turn Therapeutics Inc.
12.40$
-7.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 24 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.02 | 0.03 | |
| 0.02 | 0.09 | 0.06 | 0.07 | 0.04 | 0.04 | 0.21 | |
| 0.03 | 0.10 | 0.07 | 0.07 | 0.04 | 0.05 | 0.23 | |
| -0.03 | -0.10 | -0.07 | -0.07 | -0.04 | -0.05 | -0.23 | |
| – | – | – | – | – | 0.01 | – | |
| -0.03 | -0.09 | -0.07 | 0.01 | -0.03 | -0.20 | -0.28 | |
| -0.03 | -0.09 | -0.07 | 0.01 | -0.03 | -0.20 | -0.28 | |
| -0.03 | -0.09 | -0.07 | 0.01 | -0.03 | -0.05 | -0.14 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.